Navigate Fool.com
Will NPSP beat
the market?
Community Rating: 4 Stars: Favorite

24.55 -0.30 (-1.21%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $24.72
Previous Close $24.85
Daily Range $24.08 - $25.72
52-Week Range $11.65 - $39.68
Market Cap $2.5B
P/E Ratio -177.50
Dividend (Yield) $0.00 (0.0%)
Volume 2,045,741
Average Daily Volume 2,127,140
Current FY EPS $0.25

How do you think NPSP
will perform against the market?

Top NPSP Bull/Bear Pitches


zzlangerhans (< 20)
Submitted November 22, 2011

Recent bad news from the STEPS 2 extension study of Gattex in short bowel syndrome got me out of the red zone and into a winning red thumb on NPS. The company reported three cases of cancer occurring … More

0 Replies Reply Report this Post

cashsage (< 20)
Submitted December 17, 2009

NPSP has an illiquid balance sheet and a too high valuation compared to its sales potential. It is also loss making at least until 2011.

0 Replies Reply Report this Post

News & Commentary

Why NPS Pharmaceuticals, Inc. Shares Slipped

Does this analyst make a good case? Or is it just more noise from Wall Street?

Top Analyst Upgrades and Downgrades: Control4, Cree, NetApp, Twitter, Yahoo!, Yelp and More

Interesting NPSP Put And Call Options For November 22nd

NPSP Makes Notable Cross Below Critical Moving Average

Biotech booms on Wall Street

NPS Pharmaceuticals' Q4 Revenue Doubles as It Reverses a Year-Ago Loss

Strong sales of Gattex combined with a 44% increase in royalty revenue drive NPS' top- and bottom-lines significantly higher.

Earnings Reaction History: NPS Pharmaceuticals, 66.7% Follow-Through Indicator, 6.0% Sensitive

J.P. Morgan: Two Biotech Stocks To Buy With 65%-100% Upside

Sector Update: Healthcare Shares Flat Pre-Market; Catalyst Pharmaceutical Partners Rises 14% on Join

Sector Update: Healthcare Shares Flat Pre-Market; Catalyst Pharmaceutical Partners Rises 14% on Joint Study of Firdapse Tablets

Sector Update: Healthcare

See More NPSP News...





NPS Pharmaceuticals, Inc. (NPSP) Description

A biopharmaceutical company focused on the development and commercialization of small molecule drugs and recombinant proteins. Website: http://www.npsp.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks